Name | 1-(6-amino-3,5-difluoropyridin-2-yl)-6-fluoro-8-methyl-4-oxo-7-[3-(propan-2-ylamino)azetidin-1-yl]quinoline-3-carboxylic acid |
---|---|
Synonyms |
KPI-10 free base
WQ-3810 UNII-RTQ8P0159M WQ3810 |
Description | WQ3810 is an orally active fluoroquinolone, with potent antibacterial activities. |
---|---|
Related Catalog | |
In Vitro | WQ-3810 shows potent activity against A. baumannii, including MDR isolates, with MIC90 of 1 mg/L, more than eight-fold higher than that of ciprofloxacin (64 mg/L) and levofloxacin (8 mg/L). WQ-3810 also exhibits inhibitory effects on E. coli and S. pneumoniae, including FQR isolates, with MIC90 of 4 mg/L and 0.06 mg/L, respectively. WQ-3810 is the most potent among the fluoroquinolones tested against meticillin-resistant Staphylococcus aureus (MRSA) and Neisseria gonorrhoeae, including FQR isolates[1]. |
References |
Molecular Formula | C22H22F3N5O3 |
---|---|
Molecular Weight | 461.43700 |
Exact Mass | 461.16700 |
PSA | 114.21000 |
LogP | 2.96440 |